42 Results for "

spasticity

" in MedChemExpress (MCE) Product Catalog:
Products (42)

42 Results for "spasticity" in MCE Product Catalog:

13
13 Publications Verification
Cat. No.: HY-B0007
CAS No.: 1134-47-0
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Baclofen, a lipophilic derivative of γ-aminobutyric acid (GABA), is an orally active, selective metabotropic GABAB receptor (GABABR) agonist with blood-brain barrier permeability. Baclofen mimics the action of GABA and produces slow presynaptic inhibition through the GABAB receptor. Baclofen has high blood brain barrier penetrance. Baclofen has the potential for muscle spasticity research .
loading...
    loading...
13
13 Publications Verification
Cat. No.: HY-B0007C
CAS No.: 28311-31-1
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Baclofen hydrochloride, a lipophilic derivative of γ-aminobutyric acid (GABA), is an orally active, selective metabotropic GABAB receptor (GABABR) agonist. Baclofen hydrochloride mimics the action of GABA and produces slow presynaptic inhibition through the GABAB receptor. Baclofen hydrochloride has high blood brain barrier penetrance. Baclofen hydrochloride has the potential for muscle spasticity research .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-12640
CAS No.: 22204-24-6
Purity:  99.97%
Synonyms: Pyrantel embonate
Target:  

Parasite nAChR

Research Areas:  

Infection

Pyrantel pamoate is an orally active antiparasitic agent. Pyrantel pamoate induces spastic paralysis in parasites via actions on neural and muscular cholinergic receptors as a nicotinic acetylcholine receptor (nAChR) agonist. Pyrantel pamoate eliminates both immature and mature endoparasites in horses. Pyrantel pamoate can be used in research related to parasitic infections .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B1139
CAS No.: 3644-61-9
Target:  

Apoptosis

Research Areas:  

Neurological Disease

Tolperisone hydrochloride is a centrally acting muscle relaxant studied in neurological disorders causing pathological rhabdomyosclerosis (pyramidal tract injury, multiple sclerosis, myelopathy, encephalomyelitis), spastic paralysis, and other muscle dystonia-related Encephalopathy. Tolperisone hydrochloride also has antiviral activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-148516
CAS No.: 2649776-79-2
Purity:  99.25%
Target:  

Myosin

Research Areas:  

Neurological Disease

MPH-220 is a selective and orally active inhibitor of skeletal muscle myosin-2. MPH-220 enables muscle relaxation. MPH-220 is anti-spastic agent that can be used in the research of spasticity and muscle stiffness .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1283
CAS No.: 59-47-2
Target:  

iGluR

Research Areas:  

Neurological Disease

Mephenesin is an NMDA receptor antagonist. Mephenesin is also a central muscle relaxant with antianxiety, muscle-paralyzing and anticonvulsant effects. Mephenesin acts directly on the skeletal muscle fibres to produce skeletal muscle relaxation. Mephenesin is promising for research of spasticity or painful muscle spasm .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-12641
CAS No.: 33401-94-4
Purity:  98.69%
Target:  

Parasite nAChR

Research Areas:  

Infection

Pyrantel tartrate is an orally active antiparasitic agent. Pyrantel tartrate induces spastic paralysis in parasites via actions on neural and muscular cholinergic receptors as a nicotinic acetylcholine receptor (nAChR) agonist. Pyrantel tartrate eliminates both immature and mature endoparasites in horses. Pyrantel tartrate can be used in research related to parasitic infections .
loading...
    loading...
Cat. No.: HY-B0194
CAS No.: 51322-75-9
Tizanidine, a skeletal muscle relaxant, is an orally effective central α2-adrenoceptor agonist (IC50 = 6.9 nmol). Tizanidine primarily exerts muscle relaxation effects by inhibiting the release of excitatory amino acids (glutamate and aspartate) from the presynaptic terminals of spinal cord interneurons. Tizanidine has anti-injury activity and can inhibit gastrointestinal (GI) transport. Tizanidine can inhibit the proliferation, migration, and invasion of lung cancer cells and induce cell apoptosis by upregulating Nischarin and inhibiting the AKT and Wnt3a/β-catenin signaling pathways. Tizanidine can be used to treat spasticity caused by diseases such as multiple sclerosis (MS), stroke, and spinal cord injury (SCI) .
loading...
    loading...
Cat. No.: HY-B0194A
CAS No.: 64461-82-1
Tizanidine hydrochloride, a skeletal muscle relaxant, is an orally effective central α2-adrenoceptor agonist (IC50 = 6.9 nmol). Tizanidine hydrochloride primarily exerts muscle relaxation effects by inhibiting the release of excitatory amino acids (glutamate and aspartate) from the presynaptic terminals of spinal cord interneurons. Tizanidine hydrochloride has anti-injury activity and can inhibit gastrointestinal (GI) transport. Tizanidine hydrochloride can inhibit the proliferation, migration, and invasion of lung cancer cells and induce cell apoptosis by upregulating Nischarin and inhibiting the AKT and Wnt3a/β-catenin signaling pathways. Tizanidine hydrochloride can be used to treat spasticity caused by diseases such as multiple sclerosis (MS), stroke, and spinal cord injury (SCI) .
loading...
    loading...
Cat. No.: HY-12640R
CAS No.: 22204-24-6
Synonyms: Pyrantel embonate (Standard)
Research Areas:  

Infection

Pyrantel pamoate (Standard) (Pyrantel embonate (Standard)) is the analytical standard of Pyrantel pamoate (HY-12640). This product is intended for research and analytical applications. Pyrantel pamoate is an orally active antiparasitic agent. Pyrantel pamoate induces spastic paralysis in parasites via actions on neural and muscular cholinergic receptors as a nicotinic acetylcholine receptor (nAChR) agonist. Pyrantel pamoate eliminates both immature and mature endoparasites in horses. Pyrantel pamoate can be used in research related to parasitic infections .
loading...
    loading...
Cat. No.: HY-B0194S
CAS No.: 1188331-19-2
Tizanidine-d4 is the deuterium labeled Tizanidine (HY-B0194). Tizanidine, a skeletal muscle relaxant, is an orally effective central α2-adrenoceptor agonist (IC50 = 6.9 nmol). Tizanidine primarily exerts muscle relaxation effects by inhibiting the release of excitatory amino acids (glutamate and aspartate) from the presynaptic terminals of spinal cord interneurons. Tizanidine has anti-injury activity and can inhibit gastrointestinal (GI) transport. Tizanidine can inhibit the proliferation, migration, and invasion of lung cancer cells and induce cell apoptosis by upregulating Nischarin and inhibiting the AKT and Wnt3a/β-catenin signaling pathways. Tizanidine can be used to treat spasticity caused by diseases such as multiple sclerosis (MS), stroke, and spinal cord injury (SCI).
loading...
    loading...
Cat. No.: HY-148516A
Purity:  99.09%
Target:  

Myosin

Research Areas:  

Neurological Disease

(R)-MPH-220 is the R isomer of MPH-220 (HY-148516). MPH-220 is a selective and orally active inhibitor of skeletal muscle myosin-2. MPH-220 enables muscle relaxation. MPH-220 is anti-spastic agent that can be used in the research of spasticity and muscle stiffness .
loading...
    loading...
Cat. No.: HY-110411
CAS No.: 4611-02-3
Target:  

Drug Derivative

Research Areas:  

Neurological Disease

Chlorproethazine hydrochloride is an orally active phenothiazine compound. Chlorproethazine hydrochloride can eliminate spasticity when administered intravenously and also effectively reduce rigidity in decerebrate cats. Chlorproethazine hydrochloride can be used in the research of neurological diseases .
loading...
    loading...
Cat. No.: HY-B0007A
CAS No.: 63701-56-4
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

(S)-Baclofen hydrochloride is a GABAB receptor agonist that crosses the blood-brain barrier and is orally active, with IC50 values ​​of 1.77 μM for GABAB and 1564 μM for GABAA. (S)-Baclofen hydrochloride can be used in research on muscle disorders such as spasticity .
loading...
    loading...
Cat. No.: HY-12641A
CAS No.: 15686-83-6
Target:  

Parasite nAChR

Research Areas:  

Infection

Pyrantel is an orally active antiparasitic agent. Pyrantel induces spastic paralysis in parasites via actions on neural and muscular cholinergic receptors as a nicotinic acetylcholine receptor (nAChR) agonist. Pyrantel eliminates both immature and mature endoparasites in horses. Pyrantel can be used in research related to parasitic infections .
loading...
    loading...
Cat. No.: HY-B0007R
CAS No.: 1134-47-0
Research Areas:  

Neurological Disease

Baclofen (Standard) is the analytical standard of Baclofen. This product is intended for research and analytical applications. Baclofen, a lipophilic derivative of γ-aminobutyric acid (GABA), is an orally active, selective metabotropic GABAB receptor (GABABR) agonist. Baclofen mimics the action of GABA and produces slow presynaptic inhibition through the GABAB receptor. Baclofen has high blood brain barrier penetrance. Baclofen has the potential for muscle spasticity research .
loading...
    loading...
Cat. No.: HY-B0007S2
CAS No.: 2012598-58-0
Baclofen-d5 hydrochloride is deuterated labeled Baclofen (HY-B0007). Baclofen, a lipophilic derivative of γ-aminobutyric acid (GABA), is an orally active, selective metabotropic GABAB receptor (GABABR) agonist. Baclofen mimics the action of GABA and produces slow presynaptic inhibition through the GABAB receptor. Baclofen has high blood brain barrier penetrance. Baclofen has the potential for muscle spasticity research .
loading...
    loading...
Cat. No.: HY-B1139A
CAS No.: 728-88-1
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

Tolperisone, a centrally acting muscle relaxant, is utilized for alleviating symptoms of spasticity and muscle spasms.
loading...
    loading...
Cat. No.: HY-152190
CAS No.: 30408-07-2
Purity:  99.32%
Target:  

Myosin

Research Areas:  

Cardiovascular Disease

JB002 is a myosin II inhibitor, with an IC50 of ≤10 μM. JB002 can be used for the research of muscle spasticity, chronic musculoskeletal pain, and hypertrophic cardiomyopathy .
loading...
    loading...
Cat. No.: HY-B0007B
CAS No.: 66514-99-6
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

(S)-Baclofen is a GABAB receptor agonist that crosses the blood-brain barrier and is orally active, with IC50 values ​​of 1.77 μM for GABAB and 1564 μM for GABAA. (S)-Baclofen can be used in research on muscle disorders such as spasticity .
loading...
    loading...